Nyrada Inc - Asset Resilience Ratio

Latest as of June 2025: 55.29%

Nyrada Inc (NYR) has an Asset Resilience Ratio of 55.29% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Nyrada Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$2.93 Million

≈ $2.07 Million USD Cash + Short-term Investments

Total Assets

AU$5.30 Million

≈ $3.75 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2022)

This chart shows how Nyrada Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NYR asset base.

Liquid Assets Composition Over Time

This chart breaks down Nyrada Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Nyrada Inc debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.93 Million	55.29%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.93 Million	55.29%

Asset Resilience Insights

Very High Liquidity: Nyrada Inc maintains exceptional liquid asset reserves at 55.29% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Nyrada Inc Industry Peers by Asset Resilience Ratio

Compare Nyrada Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Genscript Biotech Corporation F:G51	Biotechnology	13.79%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
89bio Inc NASDAQ:ETNB	Biotechnology	71.60%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	2.66%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%

Annual Asset Resilience Ratio for Nyrada Inc (2021–2022)

The table below shows the annual Asset Resilience Ratio data for Nyrada Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-06-30	90.03%	AU$10.82 Million ≈ $7.65 Million	AU$12.01 Million ≈ $8.50 Million	-0.70pp
2021-06-30	90.72%	AU$13.75 Million ≈ $9.73 Million	AU$15.16 Million ≈ $10.72 Million	--

pp = percentage points

About Nyrada Inc

AU:NYR Australia Biotechnology

Market Cap

$126.52 Million

AU$178.81 Million AUD

Market Cap Rank

#18402 Global

#577 in Australia

Share Price

AU$0.73

Change (1 day)

+0.00%

52-Week Range

AU$0.29 - AU$1.38

All Time High

AU$1.38